MiR-140-5p targets BCL2L1 to promote cardiomyocyte apoptosis
M.-Y. Sun, L.-P. Li Department of Clinical Laboratory, Jining No. 1 People’s Hospital, Jining, China.
The article “MiR-140-5p targets BCL2L1 to promote cardiomyocyte apoptosis, by M.-Y. Sun, L.-P. Li, published in Eur Rev Med Pharmacol Sci 2020; 24 (11): 6311-6322–DOI: 10.26355/eurrev_202006_21529–PMID: 32572928” has been withdrawn from the authors.
They stated that “they are still working on this study” and that “they found some current experimental results which are inconsistent with the previous ones. Moreover, they added that “these inconsistent results may be caused by the contamination of the previous experimental cell lines”.
The Publisher apologizes for any inconvenience this may cause.
Free PDF DownloadMiR-140-5p targets BCL2L1 to promote cardiomyocyte apoptosis
This work is licensed under a Creative Commons Attribution-NonCommercial-NoDerivatives 4.0 International License
To cite this article
M.-Y. Sun, L.-P. Li
MiR-140-5p targets BCL2L1 to promote cardiomyocyte apoptosis
Eur Rev Med Pharmacol Sci
Year: 2021
Vol. 25 - N. 1
Pages: 1-1
DOI: 10.26355/eurrev_202101_24298